A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who ...

Working closely with internal teams, the students gain firsthand insight into real-world applications, fostering a startup ...

Evernorth said that through direct negotiations with Novo Nordisk and Eli Lilly, patients’ monthly copay costs for Wegovy ...

CI gains 14.7% YTD as Evernorth and Cigna Healthcare drive growth, but rising expenses and debt pose challenges.

Vermont Business Magazine This week, the Hinesburg community celebrated the official grand opening of Kelley’s Field II.

Cigna’s Evernorth has reached new deals with manufacturers Eli Lilly and Novo Nordisk to cap patients’ copays for pricey GLP-1 weight loss medications, the health services business announced ...

House appropriators advanced a bill to fund the FDA for fiscal 2026 on a party-line vote out of a subcommittee Thursday — but ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Express Scripts by Evernorth, the pharmacy benefits business of The Cigna Group, and its affiliated pharmacies, filed a ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at $200 per month for patients using the weight-loss drugs - Wegovy from ...

Officials held a ribbon-cutting on Wednesday for Kelley’s Field II, a new independent living community in Hinesburg.